Skip to content
Riskpilot
← Back to search
Sign in
Get full access
QIAGEN DNA Synthesis AB
AB
Active
Org 5563785046
Pressduktorgränd 6, 721 36
Västerås
Manufacture of other chemical products n.e.c.
· NACE 2059
Est. 1989
90 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of other chemical products n.e.c.
/
QIAGEN DNA Synthesis AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
41M
83M
124M
166M
130M
2020
86M
2021
78M
2022
100M
2023
144M
2024
EBITDA
SEK millions
0M
5M
9M
14M
18M
-2M
2020
-23M
2021
-40M
2022
-20M
2023
16M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
130 196
85 547
78 460
100 080
143 987
Staff expenses
—
—
—
—
—
EBITDA
−1 841
−22 804
−40 223
−19 815
16 046
Depreciation & amort.
−3 971
−7 261
−8 021
−10 995
−11 405
EBIT
−5 812
−30 065
−48 244
−30 810
4 641
Net financials
−1 611
−2 434
−4 957
−8 799
−7 247
Profit before tax
−7 423
−32 499
−53 200
−32 109
−2 606
Tax
1 530
−2 783
−0
−0
−13
Net profit
−5 893
−35 282
−53 200
−32 109
−2 619
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
149 291
142 408
159 529
168 562
150 992
Equity
47 456
12 174
18 973
36 864
34 245
Long-term debt
0
0
0
0
0
Short-term debt
101 835
130 234
140 555
131 698
116 747
Total debt
101 835
130 234
140 555
131 698
116 747
Financial ratios
5-year trend
EBITDA margin
11.1%
This company
15.8%
Market median
-30% vs market
2020
2024
Equity ratio
22.7%
This company
38.2%
Market median
-41% vs market
2020
2024
Return on equity
-7.6%
This company
18.4%
Market median
-141% vs market
2020
2024
Net profit margin
-1.8%
This company
8.1%
Market median
-122% vs market
2020
2024
Asset turnover
0.95×
This company
1.12×
Market median
+15% vs market
2020
2024
Debt / equity
3.41×
This company
0.62×
Market median
-450% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on QIAGEN DNA Synthesis AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
